[1]
Baser, O. et al. 2024. Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide. Acta Oncologica. 63, 1 (Apr. 2024), 137–146. DOI:https://doi.org/10.2340/1651-226X.2024.20337.